Clinical Trial Update: Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances

View source ↗

Summary

This update reports on the prevalence of lipodystrophy syndrome and its role as a cause of metabolic disturbances based on the completed NCT02614027 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipodystrophy
• Metabolic Syndrome

Snippet

Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas | Conditions: Lipodystrophy, Metabolic Syndrome | Status: COMPLETED